| Co-Investigator(Kenkyū-buntansha) |
EGUCHI Yutaka 大阪大学, 大学院・医学系研究科, 准教授 (20243214)
SHINZAWA Koei 大阪大学, 大学院・医学系研究科, 助教 (70403186)
SHIBUYA Toshiharu 大阪大学, 大学院・医学系研究科, 助教 (70448033)
HAMADA Yoshio 基礎生物学研究所, 細胞社会学, 助教 (10132739)
恵口 豊 大阪大学, 医学系研究科, 准教授 (20243206)
|
|---|
| Budget Amount *help |
¥545,610,000 (Direct Cost: ¥419,700,000、Indirect Cost: ¥125,910,000)
Fiscal Year 2011: ¥109,980,000 (Direct Cost: ¥84,600,000、Indirect Cost: ¥25,380,000)
Fiscal Year 2010: ¥109,980,000 (Direct Cost: ¥84,600,000、Indirect Cost: ¥25,380,000)
Fiscal Year 2009: ¥109,980,000 (Direct Cost: ¥84,600,000、Indirect Cost: ¥25,380,000)
Fiscal Year 2008: ¥105,170,000 (Direct Cost: ¥80,900,000、Indirect Cost: ¥24,270,000)
Fiscal Year 2007: ¥110,500,000 (Direct Cost: ¥85,000,000、Indirect Cost: ¥25,500,000)
|
|---|
| Research Abstract |
Based on our hypothesis that non-apoptotic cell death mechanisms play an important role in physiological programmed death in addition to pathological death, we have performed detailed studies and discovered that non-apoptotic death mechanisms play the major role in programmed death involved in turn over of mouse small intestinal epithelial cells, placenta formation, and bone formation as well as in pathological death of neurons in INAD model mouse withmutations in PLA2G6 gene. This implies that cell death research needs the paradigm shift. We have also found some chemical inhibitors or genes for theabove-mentioned non-apoptotic programmed death and for non-apoptotic death,which we observed in cultured cells, providing the firm basis for the next generation of cell death research.
|
